Clinical Research Directory
Browse clinical research sites, groups, and studies.
STEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning
Sponsor: Chinese University of Hong Kong
Summary
The STEAM-MAP 1 Study is a single-arm, prospective feasibility trial evaluating the integration of MRI-transrectal ultrasound (TRUS) fusion guidance into Rezūm water vapor thermal therapy for men with symptomatic benign prostatic hyperplasia (BPH).
Official title: Prospective Feasibility Trial on MRI-TRUS Fusion Water Vapour Ablation for Benign Prostatic Hyperplasia (STEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning)
Key Details
Gender
MALE
Age Range
30 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2026-06-01
Completion Date
2028-03-31
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Interventions
MRI-TRUS fusion-guided Rezūm therapy
This study involves MRI-TRUS fusion-guided planning and delivery of Rezūm water vapor thermal therapy for men with symptomatic benign prostatic hyperplasia (BPH). All participants will receive the investigational workflow during their Rezūm procedure. This is a single-arm study with no concurrent control group.
Locations (3)
Prince of Wales Hospital
Shatin, Hong Kong
North District Hospital
Sheung Shui, Hong Kong
Alice Ho Miu Ling Nethersole Hospital
Tai Po, Hong Kong